Prostate cancer is the second most common cancer among men in the United States and the most common cancer in men over 50. In fact, one in seven men will be diagnosed with prostate cancer in their lifetime.
Although incidence rates are high, there is reason for hope for the future of prostate cancer in Orange County and nationwide. “Prostate cancer is highly treatable when caught early and when care is provided by highly trained, specialized experts using the most advanced treatments and technologies available,” says Jeffrey S. Yoshida, M.D., the medical director of urologic surgery at City of Hope Orange County.
Yoshida is nationally recognized for his expertise and exceptional patient care. He has performed nearly 4,000 robotic surgical procedures on the state-of-the-art da Vinci robotic system for patients with prostate cancer who require surgical intervention.
“For many patients, minimally invasive surgery is a common treatment option,” Yoshida says. “Robotic surgery typically offers patients fewer side effects and faster recovery. City of Hope pioneered these procedures and has performed thousands of robotic surgeries for prostate and other urologic cancers, more than any other hospital in the western United States.”
Innovative Biopsy Method
City of Hope Orange County offers the gold standard of prostate cancer testing: targeted, transperineal prostate biopsies.
This new biopsy method is more comfortable for the patient, highly effective in diagnosing cancer and may reduce any anxiety connected to prostate cancer screening. The biopsy procedures are performed by Yoshida and his team at City of Hope Orange County Lennar Foundation Cancer Center — the most advanced comprehensive cancer center in Orange County.
By combining this biopsy with special MRI scans, City of Hope Orange County can increase the accuracy of detecting abnormalities in the prostate, reducing the likelihood of false negatives and the need for subsequent biopsies.
For men who cannot have an MRI, City of Hope Orange County is the only facility in the region to offer PSMA PET-ultrasound fusion prostate biopsy — a capability that is greatly improving prostate cancer surveillance strategies.
Not all patients coming to City of Hope Orange County will need to undergo a biopsy. While many physicians believe a biopsy is the first approach for diagnosing the presence of cancer, Yoshida takes the extra step of evaluating the patient with other tests to determine if a biopsy is necessary.
Yoshida’s team takes a comprehensive and multidisciplinary approach to prostate cancer treatment. Because City of Hope Orange County provides comprehensive services at its Irvine campus, patients receive highly coordinated care and can often see multiple specialists at the cancer center in the same day.
Renowned Prostate Cancer Treatment
City of Hope has one of the largest prostate cancer programs in the Western United States. Our five-year survival rate is close to 100% and we offer superior outcomes for stages 1-4 prostate cancer.
City of Hope also offers patients greater access to many prostate cancer clinical studies, from identifying biomarkers for better cancer detection to using reengineered immune cells to target prostate cancer throughout the body.
Our physicians and researchers are developing and evaluating new therapies for prostate cancer that travel from the lab to patients with lifesaving speed.
Discoveries made at City of Hope impact more than 100 million lives around the world annually. When cancer and only cancer is the focus, survival happens. First in research. First in treatment. First in survival.
When it comes to cancer, it’s Hope First.
888.333.HOPE (4673) | CityofHope.org/OC